The rising pattern points at your ovaries, not your stress
The FDA has expressed concerns about compounded semaglutide, primarily because of reports about patients accidentally taking too much
Ms Raffoul described it as a timely move
This may change the paradigm of how we view overweight and obesity as cardiovascular risk factors and not just cosmetic concerns and will hopefully expand insurance coverage and access for these medications for weight loss, she says
Avoid leaving medication on un-refrigerated buses or in hot excursion vehicles
GLP-1 injections are typically administered once weekly, depending on the specific formulation, and are most effective when combined with a structured care plan that includes nutritional support, physical activity, and regular medical follow-up